Breast Milk News and Research

RSS

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

Bristol-Myers Squibb Company announced today that 14 abstracts on the Company's research in liver disease have been accepted for presentation at The International Liver CongressTM 2013, the 48th annual meeting of the European Association for the Study of the Liver, in Amsterdam, April 24 - 28.

8 Apr 2013

UC Davis scientists find mechanism in metabolized omega-3 fatty acid that helps combat cancer

A team of UC Davis scientists has found that a product resulting from a metabolized omega-3 fatty acid helps combat cancer by cutting off the supply of oxygen and nutrients that fuel tumor growth and spread of the disease.

3 Apr 2013

Study investigates new way to treat necrotizing enterocolitis

Stem cells taken from amniotic fluid were used to restore gut structure and function following intestinal damage in rodents, in new research published in the journal Gut.

25 Mar 2013

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced the U.S. Food and Drug Administration (FDA) has approved ABILIFY MAINTENA (aripiprazole) for extended- release injectable suspension, an intramuscular (IM) depot formulation indicated for the treatment of schizophrenia.

1 Mar 2013

C-section babies more likely to develop allergies

For expectant moms who may contemplate the pros and cons of natural child birth or Caesarian section, a Henry Ford Hospital study suggests that C-section babies are susceptible to developing allergies by age two.

25 Feb 2013

Opinion pieces address Save the Children breastfeeding report

Save the Children on Monday released a report examining "the four major barriers that prevent mothers from breastfeeding" -- community and cultural pressures, the shortage of health workers, a lack of maternity legislation, and inappropriate promotion of breast-milk substitutes."

21 Feb 2013

Feeding human breast milk to very-low-birth-weight infants reduces risk of sepsis and NICU costs

Feeding human breast milk to very-low-birth-weight infants greatly reduces risk for sepsis and significantly lowers associated neonatal intensive care unit (NICU) costs, according to a study by Rush University Medical Center researchers.

6 Feb 2013

Potential connection between autism and insulin-like growth factor

A New York-based physician-researcher from Touro College of Osteopathic Medicine, best known for his research into fertility and twinning, has uncovered a potential connection between autism and a specific growth protein that could eventually be used as a way to predict an infant's propensity to later develop the disease.

2 Feb 2013

Tacrolimus breast milk transfer concerns allayed

Breastfeeding mothers taking tacrolimus do not pass the immunosuppressant on to their babies when breastfeeding, study results show.

29 Jan 2013

Women taking tacrolimus drug can breast feed their babies

Women taking the immunosuppressant tacrolimus can rest assured that breast feeding will not elevate their babies' exposure to the drug, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

24 Jan 2013

Concern over privacy in neonatal intensive care units

Researchers say that privacy is a problem for breastfeeding mothers of newborns in the neonatal intensive care unit.

21 Jan 2013

FDA approves Allergan’s BOTOX to treat overactive bladder

Allergan, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved BOTOX (onabotulinumtoxinA) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency in adults who have had an inadequate response to or are intolerant of an anticholinergic medication.

19 Jan 2013

Many mothers of newborns in NICUs lack privacy to breastfeed

Many mothers of newborns in neonatal intensive care units have difficulty finding private, quiet places in the hospital to express milk, according to a new study from the Frances Payne Bolton School of Nursing at Case Western Reserve University.

17 Jan 2013

Pfizer’s Quillivant XR now available in the U.S. for treatment of ADHD

Pfizer Inc. today announced that Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension is now available in the U.S. for the treatment of attention deficit hyperactivity disorder (ADHD).

16 Jan 2013

Glycan released by parasites might help treat metabolic disorders associated with obesity

On the list of undesirable medical conditions, a parasitic worm infection surely ranks fairly high. Although modern pharmaceuticals have made them less of a threat in some areas, these organisms are still a major cause of disease and disability throughout much of the developing world.

9 Jan 2013

Study reveals large microbial diversity in breast milk

Spanish researchers have traced the bacterial microbiota map in breast milk, which is the main source of nourishment for newborns. The study has revealed a larger microbial diversity than originally thought: more than 700 species.

4 Jan 2013

Breast milk banks: an interview with Dr. Pieter Koorts

The available literature clearly demonstrates that in almost all circumstances a mother’s own breast milk is the ideal food for her infant. This is particularly important for preterm infants. Preterm infants are babies born before 37 completed weeks of pregnancy.

5 Dec 2012

Study identifies risk factors associated with co-exposure to lead, mercury and PCBs

Nearly 23 percent of American women of childbearing age met or exceeded the median blood levels for all three environmental chemical pollutants - lead, mercury, and PCBs - tracked in an analysis of data on thousands of women by Brown University researchers.

29 Nov 2012

Omega-3 fatty acids can benefit women at risk of postpartum depression

The "feel-good" hormone serotonin, depleted by pregnancy, can be replenished by adding sources of omega-3 to the diets of pregnant women and new mothers - a development particularly beneficial to the 10 to 15 percent of women at risk for postpartum depression, according to a recent University of Montreal study published in the latest edition of the Canadian Journal of Psychiatry.

29 Nov 2012

Pfizer completes acquisition of NextWave Pharmaceuticals

Pfizer Inc. today announced that it has completed its acquisition of NextWave Pharmaceuticals, Inc., a privately held, specialty pharmaceutical company focused on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD).

29 Nov 2012